Rossmax portatīvais pistonu nebulizators NH60 (JAUNUMS)

Handheld Piston Nebulizer Rossmax NH60 Particle size created by our VAT bottle is around 2.43 μm (MMAD) tested by Cascade Impactor. Compared to most bottles in the market, our proprietary bottle ensures more efficient and effective performance. MMAD ≤2.43 μm; Fine Particle Dose (FPD): 75-80% Consistent fine particle size for efficient respiratory treatment Patented Valve Adjustable nebulizer bottle (VAT) Mini Pump Technology Handheld & Tubeless design Low noise and quiet Very compact (6.3 x 6.4 x 15 cm) Mouthpiece and masks for adult and child included 12V Adaptor included Valve Adjustable Technology The proprietary adjustable valve is able to deliver medications of different viscosity level according to every user’s conditions and needs at ease. Our VAT technology allows users to adjust different levels of nebulization rate ranging from 0.08 – 0.20 ml/min at consistent particle size. The nebulization rates can be adjusted by the user in a very easy way without exchanging parts. High nebulization rate/full open is for high viscosity medications and high breathing capacity user while low flow rate with close valve will be more appropriate for kids / infants with lower breathing capacity. Thanks to the reduction of wasted medication, VAT is also recommended for respiratory disorders such as COPD and Asthma as well as intensive use in general. The following Nebulizers are equipped with our VA Technology. Mini Pump Tailor-made for mini nebulizer - The mini pump is a brand new design for small portable nebulizer. The components of the pump are of the highest quality and manufactured by Rossmax Japan. Moreover, the pump is tailor-made which means that the pump’s characteristics and functionality can be set and adjusted to meet nebulizer specifications. Efficent Respiratory Utilizing the new technologies to improve the management and treatment of asthma, COPD and other respiratory conditions. With nebulizer systems, patients have the ability to effectively manage and treat their respiratory condition anywhere, anytime. MMAD : 2.43μm